PROFOUND MEDICAL CORP. Depreciation
PROFOUND MEDICAL CORP. (PROF) reported Depreciation of $126.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- PROFOUND MEDICAL CORP. depreciation for the quarter ending 2026-06-30 was $126.00K, a 23.53% increase year-over-year.
- PROFOUND MEDICAL CORP. depreciation for the quarter ending 2026-03-31 was $93.00K, a 19.83% decline year-over-year.
- PROFOUND MEDICAL CORP. depreciation for the quarter ending 2025-12-31 was $62.00K, a 61.25% decline year-over-year.
- PROFOUND MEDICAL CORP. depreciation for the quarter ending 2025-09-30 was $93.00K, a 43.29% decline year-over-year.
- PROFOUND MEDICAL CORP. depreciation for fiscal 2024 was $707.00K, a 2.75% decline from fiscal 2023.
- PROFOUND MEDICAL CORP. depreciation for fiscal 2023 was $727.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $126.00K 10-Q · filed 2026-08-06 | $219.00K 10-Q · filed 2026-08-06 | $281.00K derived: sum of 3 quarters · filed 2026-08-06 | $374.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $93.00K 10-Q · filed 2026-05-07 | $155.00K derived: sum of 2 quarters · filed 2026-08-06 | $248.00K derived: sum of 3 quarters · filed 2026-08-06 | $350.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $62.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-06 | $155.00K derived: sum of 2 quarters · filed 2026-08-06 | $257.00K derived: sum of 3 quarters · filed 2026-08-06 | $373.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $93.00K 10-Q · filed 2025-11-13 | $195.00K derived: sum of 2 quarters · filed 2026-08-06 | $311.00K 10-Q · filed 2025-11-13 | $471.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $102.00K 10-Q · filed 2026-08-06 | $218.00K 10-Q · filed 2026-08-06 | $378.00K derived: sum of 3 quarters · filed 2026-08-06 | $542.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $116.00K 10-Q · filed 2026-05-07 | $276.00K derived: sum of 2 quarters · filed 2026-05-07 | $440.00K derived: sum of 3 quarters · filed 2026-05-07 | $624.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $324.00K derived: sum of 2 quarters · filed 2026-03-05 | $508.00K derived: sum of 3 quarters · filed 2026-03-05 | $707.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $164.00K 10-Q · filed 2025-11-13 | $348.00K derived: sum of 2 quarters · filed 2025-11-13 | $547.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $184.00K 10-Q · filed 2025-08-14 | $383.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $199.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $727.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |